Evaluation of the dopamine β-hydroxylase (DβH) inhibitor nepicastat in participants who meet criteria for cocaine use disorder

In the present study, we tested the hypothesis that the potent and selective dopamine-β-hydroxylase (DβH) inhibitor nepicastat would have minimal effects on cardiovascular and pharmacokinetic parameters associated with cocaine administration and would reduce the positive subjective effects produced...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Prog Neuropsychopharmacol Biol Psychiatry
Egile Nagusiak: De La Garza, Richard, Bubar, Marcy J., Carbone, Crystal L., Moeller, F. Gerard, Newton, Thomas F., Anastasio, Noelle C., Harper, Tod A., Ware, David L., Fuller, Michael A., Holstein, Gaylyn J., Jayroe, Jason B., Bandak, Stephen I., Reiman, Kirsten Z., Neale, Ann C., Pickford, Lesley B., Cunningham, Kathryn A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2015
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4777897/
https://ncbi.nlm.nih.gov/pubmed/25602710
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pnpbp.2015.01.009
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak